[보충] 담도계 감염의 항생제 요법

대한임상진료학회에서 제1회 실전 임상진료아카데미를 개최합니다.

증증도	Community-acquired biliary infections			Healthcare-associated biliary infections
증증도	Grade I	Grade II	Grade III	Healthcare-associated biliary infections
Penicillin 기반	Ampicillin/sulbactamb is not recommended if >20% resistance rate.	Piperacillin/tazobactam	Piperacillin/tazobactam	Piperacillin/tazobactam
Cephalosporin 기반	Cefazolin, or Cefotiam, or Cefuroxime, or Ceftriaxone, or Cefotaxime ± Metronidazole Cefmetazole, Cefoxitin, Flomoxef, Cefoperazone/sulbactam	Ceftriaxone, or Cefotaxime, or Cefepime, or Cefozopran, or Ceftazidime ± Metronidazole Cefoperazone/sulbactam	Cefepime, or Ceftazidime, or Cefozopran ± Metronidazole	Cefepime, or Ceftazidime, or Cefozopran ± Metronidazole
Carbapenem 기반	Ertapenem	Ertapenem	Imipenem/cilastatin, Meropenem, Doripenem, Ertapenem	Imipenem/cilastatin, Meropenem, Doripenem, Ertapenem
Monobactam 기반	(-)	(-)	Aztreonam ± Metronidazole	Aztreonam ± Metronidazole
Fluoroquinolone 기반	Ciprofloxacin, Levofloxacin, Pazufloxacin ± Metronidazole Moxifloxacin	Ciprofloxacin, Levofloxacin, Pazufloxacin ± Metronidazole Moxifloxacin	(-)	(-)